Verma, Aaryamaan V.
Osba, Abdelrahman Abu
Azami, Samim https://orcid.org/0009-0001-4785-6063
Tao, Brendan K. https://orcid.org/0000-0001-7069-3162
Parvand, Mahraz
Khan, Haaris M. https://orcid.org/0000-0002-9884-8020
Navajas, Eduardo V.
Article History
Received: 7 March 2026
Revised: 20 March 2026
Accepted: 7 May 2026
First Online: 25 May 2026
Competing interests
: Chief Medical Officer and Scientific Advisory Board - Naegis Pharmaceuticals; Financial support (to institution) - RegenxBio, Neuracle Genetics, Kriya Therapeutics, Canadian Institute of Health Research (CIHR), Mohseni Foundation, Lotte&John Hecht Memorial Foundation.